NCT00068172 2022-06-27Study of PI-88 in Patients With Advanced MelanomaCellxpert Biotechnology Corp.Phase 1/2 Completed88 enrolled
NCT00073892 2022-06-27PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV MelanomaCellxpert Biotechnology Corp.Phase 1/2 Completed44 enrolled